Subhashini Ganesan

6PUBLICATIONS
26CO-AUTHORS
Infectious diseasesInnate immunityMajor global burdens of diseaseSensor technology (incl. chemical aspects)Emergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 12, 2025
Post-authorisation effectiveness and safety study: a multicenter observational study of the effectiveness and safety of the inactivated SARS-CoV-2 vaccine.

Nawal Alkaabi, Salah El Din Hussein Mohamed, Faduma Mohamed Ismail

|Oct 24, 2022
Durability of antibodies post vaccination with two doses of inactivated BBIBP-CorV vaccine.

Sally Mahmoud, Subhashini Ganesan, Narjes Saheb Sharif-Askari

|Jun 10, 2022
Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates.

Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan

|Sep 29, 2021
Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.

Sally A Mahmoud, Subhashini Ganesan, Shivaraj Naik

|Jul 30, 2021
Evaluation of RNA Extraction-Free Method for Detection of SARS-CoV-2 in Salivary Samples for Mass Screening for COVID-19.

Sally A Mahmoud, Subhashini Ganesan, Esra Ibrahim

|May 18, 2021
Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus.

Sally A Mahmoud, Subhashini Ganesan, Esra Ibrahim

Pageof 1